跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA GLENMARK 15 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA GLENMARK 15 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA GLENMARK 15 MG CAPSULAS DURAS EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2021
Approval ID
35be2d3a0d4a7032
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
35be2d3a0d4a7032
Drug Cima Aemps Name
LENALIDOMIDA GLENMARK 15 MG CAPSULAS DURAS EFG
Register Number
85673
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Viso Farmaceutica S.L.U.
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2021-02-09
Dosage Form
CÁPSULA DURA
Dose
15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
LENALIDOMIDA
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2021
Approval ID
35be2d3a0d4a7032
Type
Standard
Back to CIMA-AEMPS Approvals
